Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: A simple goniometer-compatible flow cell for serial synchrotron X-ray crystallography. Corrigendum.

Journal of applied crystallography·2025
Same author

Ultrahigh-mobility microbial cytochrome nanowires generate power from humidity.

Research square·2024
Same author

Outer membrane vesicles and the outer membrane protein OmpU govern <i>Vibrio cholerae</i> biofilm matrix assembly.

mBio·2024
Same author

Time-resolved serial crystallography to track the dynamics of carbon monoxide in the active site of cytochrome <i>c</i> oxidase.

Science advances·2023
Same author

A simple goniometer-compatible flow cell for serial synchrotron X-ray crystallography.

Journal of applied crystallography·2023
Same author

Effects of Radioiodine on the Nasolacrimal System.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2022

Related Experiment Videos

Thyrotoxic cardiac disease.

Peter Dahl, Sara Danzi, Irwin Klein

    Current Heart Failure Reports
    |August 30, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Hyperthyroidism can paradoxically cause heart failure due to increased heart rate and altered calcium levels. Treatment focuses on managing cardiovascular issues and restoring thyroid hormone balance.

    Related Experiment Videos

    Area of Science:

    • Cardiology
    • Endocrinology
    • Internal Medicine

    Background:

    • Hyperthyroidism, driven by excess triiodothyronine (T3), significantly impacts the cardiovascular system.
    • Key cardiovascular changes include decreased systemic vascular resistance and increased heart rate, contractility, blood volume, and cardiac output.
    • Despite enhanced cardiac performance markers, hyperthyroidism can paradoxically lead to clinical heart failure in a subset of patients.

    Purpose of the Study:

    • To elucidate the mechanisms by which hyperthyroidism leads to cardiac dysfunction and heart failure.
    • To highlight the prevalence and specific clinical presentations of heart failure in thyrotoxicosis.
    • To outline the recommended management strategies for cardiovascular complications associated with hyperthyroidism.

    Main Methods:

    • The abstract does not specify methods, but discusses physiological effects and clinical observations.
    • It reviews the pathophysiology of tachycardia-mediated mechanisms and calcium handling in thyrotoxic cardiomyopathy.
    • It addresses the emerging role of pulmonary artery hypertension in right-sided heart failure.

    Main Results:

    • Approximately 6% of thyrotoxic individuals experience heart failure symptoms, with less than 1% developing dilated cardiomyopathy.
    • Heart failure mechanisms involve tachycardia-induced diastolic dysfunction, increased cytosolic calcium, and reduced ventricular contractility.
    • Pulmonary artery hypertension is increasingly recognized as a cause of isolated right-sided heart failure, particularly in older individuals.

    Conclusions:

    • Cardiac failure in hyperthyroidism, though paradoxical, is a significant concern, especially in the elderly.
    • Management requires addressing acute cardiovascular issues, controlling heart rate, and definitive thyroid-specific therapy.
    • Restoring a euthyroid state is crucial for resolving the cardiovascular signs and symptoms of hyperthyroidism.